Gregory D. Ayers

4.2k total citations
55 papers, 2.7k citations indexed

About

Gregory D. Ayers is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Gregory D. Ayers has authored 55 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 14 papers in Molecular Biology and 12 papers in Surgery. Recurrent topics in Gregory D. Ayers's work include MRI in cancer diagnosis (5 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Gregory D. Ayers is often cited by papers focused on MRI in cancer diagnosis (5 papers), Radiomics and Machine Learning in Medical Imaging (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Gregory D. Ayers collaborates with scholars based in United States, Israel and Belgium. Gregory D. Ayers's co-authors include Jin‐Sying Lin, Mary V. Relling, William E. Evans, Robert J. Coffey, Ann Richmond, Jeffrey S. Morris, Thomas E. Yankeelov, Edward H. Lin, Galina Bogatcheva and James N. Higginbotham and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Gregory D. Ayers

55 papers receiving 2.6k citations

Peers

Countries citing papers authored by Gregory D. Ayers

Since Specialization

Citations

This map shows the geographic impact of Gregory D. Ayers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory D. Ayers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory D. Ayers more than expected).

Fields of papers citing papers by Gregory D. Ayers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory D. Ayers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory D. Ayers. The network helps show where Gregory D. Ayers may publish in the future.

Co-authorship network of co-authors of Gregory D. Ayers

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory D. Ayers. A scholar is included among the top collaborators of Gregory D. Ayers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory D. Ayers. Gregory D. Ayers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Statistical and Methodological Considerations for Randomized Controlled Trial Design in Physical Medicine and Rehabilitation 2023 ·American Journal of Physical Medicine & Rehabilitation ·Bhaskar Thakur, Gregory D. Ayers, Folefac Atem, (unknown), Nitin Jain	4
2	Incidence and Clinical Risk Factors of Post-Operative Complications following Primary Total Hip Arthroplasty: A 10-Year Population-Based Cohort Study 2023 ·Journal of Clinical Medicine ·(unknown), (unknown), Gregory D. Ayers, (unknown), (unknown), Nitin B. Jain	2
3	Does interaction occur between risk factors for revision total knee arthroplasty? 2023 ·Archives of Orthopaedic and Trauma Surgery ·(unknown), Josh DeClercq, (unknown), Gregory D. Ayers, Nitin B. Jain	1
4	Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients 2022 ·npj Precision Oncology ·Chi Yan, Sheau‐Chiann Chen, Gregory D. Ayers, Caroline A. Nebhan, Joseph T. Roland, Vivian Weiß, Douglas B. Johnson, Ann Richmond	7
5	Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade 2021 ·Molecular Cancer ·Chi Yan, Nabil Saleh, Jinming Yang, Caroline A. Nebhan, Anna E. Vilgelm, E. Premkumar Reddy, Joseph T. Roland, Douglas B. Johnson, Sheau‐Chiann Chen, Rebecca L. Shattuck-Brandt, Gregory D. Ayers, Ann Richmond	28
6	Metastatic Melanoma Patient–Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition 2020 ·Clinical Cancer Research ·Rebecca L. Shattuck-Brandt, Sheau‐Chiann Chen, Emily Murray, Christopher Andrew Johnson, (unknown), Jamye F. O’Neal, Rami N. Al‐Rohil, Caroline A. Nebhan, Vijaya Bharti, Kimberly B. Dahlman, Gregory D. Ayers, Chi Yan, Mark C. Kelley, Rondi M. Kauffmann, Mary Hooks, Ana M. Grau, Douglas B. Johnson, Anna E. Vilgelm, Ann Richmond	22
7	TSPO-targeted PET and Optical Probes for the Detection and Localization of Premalignant and Malignant Pancreatic Lesions 2020 ·Clinical Cancer Research ·Allison S. Cohen, Jun Li, Matthew R. Hight, Eliot T. McKinley, Allie Fu, (unknown), (unknown), Dawei Zhang, (unknown), Mingfeng Bai, Gregory D. Ayers, Mohammed Noor Tantawy, Jarrod A. Smith, Frank Revetta, M. Kay Washington, Chanjuan Shi, Nipun B. Merchant, H. Charles Manning	14
8	MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21 2019 ·Science Translational Medicine ·Anna E. Vilgelm, Nabil Saleh, Rebecca L. Shattuck-Brandt, (unknown), (unknown), Sheau‐Chiann Chen, Christopher Andrew Johnson, Jinming Yang, (unknown), Chi Yan, Douglas B. Johnson, Rami N. Al‐Rohil, Ensar Halilovic, Rondi M. Kauffmann, Mark C. Kelley, Gregory D. Ayers, Ann Richmond	88
9	A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia 2018 ·Cancer Discovery ·Haley E. Ramsey, Melissa A. Fischer, Taekyu Lee, Agnieszka E. Gorska, Maria P. Arrate, Londa Fuller, Kelli L. Boyd, Stephen A. Strickland, John Sensintaffar, Leah J. Hogdal, Gregory D. Ayers, Edward T. Olejniczak, Stephen W. Fesik, Michael R. Savona	254
10	Maintaining oncologic integrity with minimally invasive resection of pediatric embryonal tumors 2018 ·Surgery ·(unknown), Gregory D. Ayers, (unknown), (unknown), Katherine D. Watson, Melissa A. Hilmes, (unknown)	12
11	Mdm2 and Aurora Kinase A Inhibitors Synergize to Block Melanoma Growth by Driving Apoptosis and Immune Clearance of Tumor Cells 2014 ·Cancer Research ·Anna E. Vilgelm, Jeff S. Pawlikowski, Yan Liu, Oriana E. Hawkins, Tyler A. Davis, (unknown), Kevin P. Weller, Linda W. Horton, Colt M. McClain, Gregory D. Ayers, David C. Turner, (unknown), Clinton F. Stewart, Jeffrey A. Sosman, Mark C. Kelley, Jeffrey Ecsedy, Jeffrey N. Johnston, Ann Richmond	82
12	Myeloid IKKβ Promotes Antitumor Immunity by Modulating CCL11 and the Innate Immune Response 2014 ·Cancer Research ·Jinming Yang, Oriana E. Hawkins, Whitney Barham, Pavlo Gilchuk, Mark Boothby, Gregory D. Ayers, Sebastian Joyce, Michael Karin, Fiona E. Yull, Ann Richmond	36
13	CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways 2014 ·Molecular Biology of the Cell ·Tammy Sobolik, Yingjun Su, Sam Wells, Gregory D. Ayers, Rebecca S. Cook, Ann Richmond	74
14	Assessing reproducibility of diffusion-weighted magnetic resonance imaging studies in a murine model of HER2+ breast cancer 2013 ·Magnetic Resonance Imaging ·Jennifer G. Whisenant, Gregory D. Ayers, Mary E. Loveless, Stephanie L. Barnes, Daniel C. Colvin, Thomas E. Yankeelov	27
15	Imaging analysis of hepatoblastoma resectability across neoadjuvant chemotherapy 2013 ·Journal of Pediatric Surgery ·Andrew J. Murphy, Gregory D. Ayers, Melissa A. Hilmes, Kaushik Mukherjee, Kevin Wilson, (unknown), Israel Fernández‐Pineda, Myrick C. Shinall, Zhiguo Zhao, Wayne L. Furman, M. Beth McCarville, Andrew M. Davidoff, Harold N. Lovvorn	13
16	Amide proton transfer imaging of the breast at 3 T: Establishing reproducibility and possible feasibility assessing chemotherapy response 2012 ·Magnetic Resonance in Medicine ·Adrienne N. Dula, Lori R. Arlinghaus, Richard Dortch, Blake E. Dewey, Jennifer G. Whisenant, Gregory D. Ayers, Thomas E. Yankeelov, Seth A. Smith	140
17	Assessing the reproducibility of dynamic contrast enhanced magnetic resonance imaging in a murine model of breast cancer 2012 ·Magnetic Resonance in Medicine ·(unknown), Jennifer G. Whisenant, Mary E. Loveless, Gregory D. Ayers, Thomas E. Yankeelov	24
18	The Safety and Efficacy of Celecoxib in Children With Familial Adenomatous Polyposis 2010 ·The American Journal of Gastroenterology ·Patrick M. Lynch, Gregory D. Ayers, (unknown), Ellen Richmond, Craig Eagle, Mabel Woloj, James M. Church, (unknown), Sherri Patterson, Elizabeth Half, Carol A. Burke	57
19	Survey of gastroenterologistsʼ awareness and implementation of AGA guidelines on osteoporosis in inflammatory bowel disease patients: Are the guidelines being used and what are the barriers to their use? 2009 ·Inflammatory Bowel Diseases ·(unknown), David A. Leiman, Gregory D. Ayers, David A. Schwartz	39
20	Synergistic interactions of the Hsp90 inhibitor 17AAG and the PI3K inhibitor LY294002 in non-small cell lung cancer (NSCLC) cell lines involve disruption of Akt and c-raf signalling 2005 ·Cancer Research ·(unknown), (unknown), Erika N. Brown, Gregory D. Ayers, Vassiliki A. Papadimitrakopoulou	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact